BRPI0416746A - processo de sìntese do perindopril e de seus sais farmaceuticamente aceitáveis - Google Patents

processo de sìntese do perindopril e de seus sais farmaceuticamente aceitáveis

Info

Publication number
BRPI0416746A
BRPI0416746A BRPI0416746-5A BRPI0416746A BRPI0416746A BR PI0416746 A BRPI0416746 A BR PI0416746A BR PI0416746 A BRPI0416746 A BR PI0416746A BR PI0416746 A BRPI0416746 A BR PI0416746A
Authority
BR
Brazil
Prior art keywords
perindopril
pharmaceutically acceptable
acceptable salts
synthesis process
formula
Prior art date
Application number
BRPI0416746-5A
Other languages
English (en)
Inventor
Thierry Dubuffet
Pascal Langlois
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of BRPI0416746A publication Critical patent/BRPI0416746A/pt
Publication of BRPI0416746B1 publication Critical patent/BRPI0416746B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/47—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/72—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/73—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

"PROCESSO DE SìNTESE DO PERINDOPRIL E DE SEUS SAIS FARMACEUTICAMENTE ACEITáVEIS". A presente invenção refere-se a um processo de síntese do perindopril de fórmula (I) e de seus sais farmaceuticamente aceitáveis.
BRPI0416746-5A 2003-11-19 2004-11-18 Processo de síntese do perindopril e de seus sais farmaceuticamente aceitáveis BRPI0416746B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03292864.0 2003-11-19
EP03292864A EP1420028B1 (fr) 2003-11-19 2003-11-19 Pocédé de synthèse du perindopril et de ses sels pharmaceutiquement acceptables
PCT/FR2004/002936 WO2005054276A1 (fr) 2003-11-19 2004-11-18 Procede de synthese du perindopril et de ses sels pharmaceutiquement acceptables

Publications (2)

Publication Number Publication Date
BRPI0416746A true BRPI0416746A (pt) 2007-01-16
BRPI0416746B1 BRPI0416746B1 (pt) 2018-02-14

Family

ID=32116380

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0416746-5A BRPI0416746B1 (pt) 2003-11-19 2004-11-18 Processo de síntese do perindopril e de seus sais farmaceuticamente aceitáveis

Country Status (28)

Country Link
US (1) US7208607B1 (pt)
EP (1) EP1420028B1 (pt)
JP (1) JP4377412B2 (pt)
KR (1) KR100863394B1 (pt)
CN (1) CN100447152C (pt)
AR (1) AR047312A1 (pt)
AT (1) ATE354586T1 (pt)
AU (1) AU2004295132B2 (pt)
BR (1) BRPI0416746B1 (pt)
CA (1) CA2546506C (pt)
CY (1) CY1106544T1 (pt)
DE (1) DE60311942T2 (pt)
DK (1) DK1420028T3 (pt)
EA (1) EA010102B1 (pt)
EG (1) EG26629A (pt)
ES (1) ES2282586T3 (pt)
GE (1) GEP20084547B (pt)
MA (1) MA28144A1 (pt)
MX (1) MXPA06005607A (pt)
MY (1) MY138550A (pt)
NO (1) NO336349B1 (pt)
NZ (1) NZ546931A (pt)
PL (1) PL210769B1 (pt)
PT (1) PT1420028E (pt)
SI (1) SI1420028T1 (pt)
UA (1) UA83269C2 (pt)
WO (1) WO2005054276A1 (pt)
ZA (1) ZA200603675B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1380591B1 (fr) * 2003-08-29 2005-11-16 Les Laboratoires Servier Nouveau procédé de synthèse du perindopril et de ses sels pharmaceutiquement acceptables
NZ548212A (en) 2003-12-29 2010-07-30 Sepracor Inc Pyrrole and pyrazole DAAO inhibitors
WO2007006003A2 (en) 2005-07-06 2007-01-11 Sepracor Inc. Combinations of eszopiclone and trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-n-methyl-1-napthalenamine or trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine, and methods of treatment of menopause and mood, anxiety, and cognitive disorders
KR101294014B1 (ko) 2006-01-06 2013-08-09 선오비온 파마슈티컬스 인코포레이티드 모노아민 재흡수 저해제로서의 시클로알킬아민
US8053603B2 (en) 2006-01-06 2011-11-08 Sunovion Pharmaceuticals Inc. Tetralone-based monoamine reuptake inhibitors
DK2816024T3 (en) 2006-03-31 2017-10-30 Sunovion Pharmaceuticals Inc CHIRALE AMINER
US7884124B2 (en) 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
US7902252B2 (en) 2007-01-18 2011-03-08 Sepracor, Inc. Inhibitors of D-amino acid oxidase
MX2009012685A (es) 2007-05-31 2009-12-14 Sepracor Inc Cicloalquilaminas sustituidas con fenilo como inhibidores de la reabsorcion de monoamina.
WO2016178591A2 (en) 2015-05-05 2016-11-10 Gene Predit, Sa Genetic markers and treatment of male obesity
PH12018502155B1 (en) 2016-04-20 2024-03-27 Servier Lab Pharmaceutical composition comprising a beta blocker, a converting enzyme inhibitor and an antihypertensive or an nsaid
CN112047869B (zh) * 2020-08-20 2021-12-21 华南理工大学 一种氮杂5,6-并环化合物的合成方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2620709B1 (fr) * 1987-09-17 1990-09-07 Adir Procede de synthese industrielle du perindopril et de ses principaux intermediaires de synthese

Also Published As

Publication number Publication date
NO20062599L (no) 2006-06-06
EA200600898A1 (ru) 2006-10-27
NZ546931A (en) 2010-01-29
MY138550A (en) 2009-06-30
EG26629A (en) 2014-04-13
AU2004295132B2 (en) 2010-07-15
DE60311942T2 (de) 2007-12-06
AR047312A1 (es) 2006-01-18
CA2546506A1 (fr) 2005-06-16
AU2004295132A1 (en) 2005-06-16
CN100447152C (zh) 2008-12-31
US20070083052A1 (en) 2007-04-12
SI1420028T1 (sl) 2007-06-30
ES2282586T3 (es) 2007-10-16
UA83269C2 (uk) 2008-06-25
HK1096689A1 (en) 2007-06-08
KR100863394B1 (ko) 2008-10-14
US7208607B1 (en) 2007-04-24
EA010102B1 (ru) 2008-06-30
CN1882607A (zh) 2006-12-20
ZA200603675B (en) 2007-09-26
BRPI0416746B1 (pt) 2018-02-14
CY1106544T1 (el) 2012-01-25
CA2546506C (fr) 2010-04-06
MA28144A1 (fr) 2006-09-01
DK1420028T3 (da) 2007-06-18
EP1420028A2 (fr) 2004-05-19
EP1420028A3 (fr) 2004-05-26
ATE354586T1 (de) 2007-03-15
PT1420028E (pt) 2007-05-31
GEP20084547B (en) 2008-11-25
PL380409A1 (pl) 2007-01-22
EP1420028B1 (fr) 2007-02-21
MXPA06005607A (es) 2006-08-17
JP4377412B2 (ja) 2009-12-02
DE60311942D1 (de) 2007-04-05
NO336349B1 (no) 2015-08-03
WO2005054276A1 (fr) 2005-06-16
JP2008502587A (ja) 2008-01-31
PL210769B1 (pl) 2012-02-29
KR20060121202A (ko) 2006-11-28

Similar Documents

Publication Publication Date Title
BR0109836A (pt) Processo de sìntese de perindopril e de seus sais farmaceuticamente aceitáveis
BR0308979A (pt) Derivados de indolilmaleimida
DE60336850D1 (en) Substituierte arylcyclopropylacetamide als glucokinaseaktivatoren
BRPI0500480A (pt) processo para a sìntese de (1s)-4,5-dimetóxi- 1-(metilaminometil)-benzociclobutano e sais de adição deste, e aplicação na sìntese de ivabradina e sais de adição desta com um ácido farmaceuticamente aceitável
NO20063275L (no) Anvendelse av substituerte 2-aminotetraliner for forebyggende behandling av Parkinsons sykdom
BR9810657A (pt) "processo de preparação de um per-hidroisoindol substituìdo"
CY1106544T1 (el) Μεθοδος συνθεσεως υπερινδοπριλης και τα φαρμακευτικως αποδεκτα αλατα αυτης
BR0301667A (pt) Processo para a preparação de polìmeros em emulsão com pureza elevada
BRPI0409095A (pt) processos de sìntese do ácido (2s)-indolina-2-carboxìlico, e aplicação para a sìntese do perindopril
BRPI0507334A (pt) processo para a preparação de -1(2s,3s)-2-benzidril-n-(5-terc-butil-2-metoxibenzila)q uinuclidin-3-amina
MY136938A (en) New process for the synthesis of perindopril and its pharmaceutically acceptable salts
EA200501925A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
BRPI0417423A (pt) processo de sìntese de perindopril e de seus sais farmaceuticamente aceitáveis
BRPI0413169A (pt) processo de sìntese do perindopril e de seus sais farmaceuticamente aceitáveis
CO5570673A2 (es) Compuestos azapoliciclicos condensados con arilo
MY135359A (en) New process for the synthesis of perindopril and pharmaceutically acceptable salts thereof
MY136288A (en) New process for the synthesis of perindopril and its pharmaceutically acceptable salts
BRPI0406893A (pt) Derivados de acilaminotiazol, a respectiva preparação e a respectiva utilização como inibidores da produção do peptìdeo betaamilóide
MY139348A (en) Method for synthesis of perindopril and its pharmaceutically acceptable salts
BRPI0415459A (pt) preparação de derivados de 3-azabiciclo[3.1.0]hexano
MY136638A (en) New process for the synthesis of perindopril and its pharmaceutically acceptable salts
MY136989A (en) New process for the synthesis of perindopril and pharmaceutically acceptable salts thereof
BR0315508A (pt) Processo para preparação de compostos de pirazol
MY149837A (en) New process for the synthesis of perindopril and pharmaceutically acceptable salts thereof
NO20061152L (no) Ny fremgangsmate for syntese av N-(S)-1-karboksybuty)-(S)-alanin og anvendelse derav for a syntetisere perindopril

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 15A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2540 DE 10-09-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.